References
- Hinchey J, Chaves C, Appignani B, et al. A reversible posterior leukoencephalopathy syndrome NEJM 1996;334(8):494.
- Otite FO, Patel SD, Anikpezie N, et el. Demographic disparities in the incidence, clinical characteristics, and outcome of posterior revesible encephalopathy syndrome in the United States. Neurology 2023;101:e1554-59.
- Fugate JE, Hawkes MA, Rabinstein AA. Posterior reversible encephalopathy syndrome: evolving insights in diagnosis, management, and outcomes. Lancet Neurol 2025;24:789-800.
- Fugate JE. The spectrum of posterior reversible encephalopathy syndrome. Neurol Clin 2025;43:141-152.
- Li Y, Song J, Huq AM, Timilsina S, Gershwin ME. Posterior reversible encephalopathy syndrome and autoimmunity. Autoimmun Rev 2023;22:103239.
- Largeau B, Bergeron S, Auger F, et al. Experimental models of posterior reversible encephalopathy syndrome: a review from pathophysiology to therapeutic targets, Stroke 2024;55:484-493.
- Largeau B, Le Tilly U, Seutenet B, et al. Arginin vasopressin and posterior revesible encephalopathy syndrome pathophysiology: the missing link? Mol Neurobiol 2019;56:6792-6806.
- Song W, Wang Y, Kong Y, et al. Cross-sectional analysis of posterior reversible encephalopathy syndrome in pregnanat women with and without HELLP syndrome. Neurol Sci 2025;46(8):3757-3764.
- Hagenkötter B, Zayet S, Polon S, et al. Posterior reversible encephalopathy syndrome in erly lyme neuroborreliosis. Tiscks Tick Borne Dis 2024;15(6):102383.
- Triplett JD, Kutlubaev MA, Kerdome AG, Hardy T. Posterior reversible encephalopathy syndrome (PRES): diagnosis and management. Pract Neurol 2022;22:183-189.
- Harrold EC, Niamh MP, Williams LJ, Sui JS, McCaffrey JA. Palbociclib-induced posterior revesible encephalopathy syndrome: a previously unreported toxicity. J Oncol Pract 2019;15:119-121.
- Belaidi L, Baba-Hamed N, Savinelli F, Raymond E. Posterior reversible encephalopathy occurring durin treatment with palbociclib. Cureus 2021;13(7):e16604.
- Tan YY, Tan K. Hypertensive braintem encephalopathy: a diagnosis often overlooked. Clin Med 2019;19(6):511-513.
- Seet RCS, Lim ECH. Hypertensive brainstem encephalopathy. Circulation 2007;115:e310-e311.
- Liu L, Dai D, Cao F, Zhamg L, Wang X. Posterior reversible encephalopathy syndrome with spinal cord involvement but without hemispheric lesions. Medicine 2019;98(2):e13649.
- Amornpojnimman T, Suwanwong P, Setthawatcharawanich S, et al. Predictors of hospital outcomes among patients with posterior reversible encephalopathy syndrome. J Stroke Cerebrovasc Dis 2022;31(8):106579.
- Al-Salahat A, Cheung R, Dilsaver D, et al. Factors associated with mortality in posterior reversible encephalopathy syndrome: a nationwide analysis. Neurol Sci 2026;47:286.
DOI: https://doi.org/10.2478/orvtudert-2026-0001 | Journal eISSN: 2537-5059 | Journal ISSN: 1453-0953
Language: English
Page range: 1 - 14
Published on: Jul 11, 2026
Published by: Transylvanian Museum Society
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year
Keywords:
Related subjects:
© 2026 Ildikó Vastagh, Dániel Bereczki, Zsolt Tarján, published by Transylvanian Museum Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.